Cargando…
Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
(a) Summary for SGLT2i‐induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i‐induced changes in the medium CXCL1 level (each n = 4). (c) SGLT2i‐induced changes in the medium CXCL8 level (each n = 4). (d) SGLT2i‐induced changes in the medium CXCL10 level (each n = 4), (e)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021706/ https://www.ncbi.nlm.nih.gov/pubmed/35475201 http://dx.doi.org/10.1002/jgh3.12730 |
_version_ | 1784689890370256896 |
---|---|
author | Nakano, Dan Kawaguchi, Takumi Tsutsumi, Tsubasa Hayakawa, Masako Yoshio, Sachiyo Koga, Hironori Torimura, Takuji |
author_facet | Nakano, Dan Kawaguchi, Takumi Tsutsumi, Tsubasa Hayakawa, Masako Yoshio, Sachiyo Koga, Hironori Torimura, Takuji |
author_sort | Nakano, Dan |
collection | PubMed |
description | (a) Summary for SGLT2i‐induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i‐induced changes in the medium CXCL1 level (each n = 4). (c) SGLT2i‐induced changes in the medium CXCL8 level (each n = 4). (d) SGLT2i‐induced changes in the medium CXCL10 level (each n = 4), (e) SGLT2i‐induced changes in the medium M‐CSF level (each n = 4). The SGLT2i‐induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C‐X‐C motif chemokine ligand; G‐CSF, granulocyte colony‐stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M‐CSF, macrophage colony‐stimulating factor; MIP‐1α, macrophage inflammatory protein‐1α; SDF‐1α, stromal‐cell‐derived factor‐1α; TNFα, tumor necrosis factor‐α; VEGF, vascular endothelial growth factor.[Image: see text] |
format | Online Article Text |
id | pubmed-9021706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wiley Publishing Asia Pty Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-90217062022-04-25 Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells Nakano, Dan Kawaguchi, Takumi Tsutsumi, Tsubasa Hayakawa, Masako Yoshio, Sachiyo Koga, Hironori Torimura, Takuji JGH Open Brief Reports (a) Summary for SGLT2i‐induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i‐induced changes in the medium CXCL1 level (each n = 4). (c) SGLT2i‐induced changes in the medium CXCL8 level (each n = 4). (d) SGLT2i‐induced changes in the medium CXCL10 level (each n = 4), (e) SGLT2i‐induced changes in the medium M‐CSF level (each n = 4). The SGLT2i‐induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C‐X‐C motif chemokine ligand; G‐CSF, granulocyte colony‐stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M‐CSF, macrophage colony‐stimulating factor; MIP‐1α, macrophage inflammatory protein‐1α; SDF‐1α, stromal‐cell‐derived factor‐1α; TNFα, tumor necrosis factor‐α; VEGF, vascular endothelial growth factor.[Image: see text] Wiley Publishing Asia Pty Ltd 2022-03-17 /pmc/articles/PMC9021706/ /pubmed/35475201 http://dx.doi.org/10.1002/jgh3.12730 Text en © 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Reports Nakano, Dan Kawaguchi, Takumi Tsutsumi, Tsubasa Hayakawa, Masako Yoshio, Sachiyo Koga, Hironori Torimura, Takuji Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title | Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title_full | Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title_fullStr | Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title_full_unstemmed | Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title_short | Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells |
title_sort | effects of sglt2 inhibitor on tumor‐releasing chemokines/cytokines in hep3b and huh7 cells |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021706/ https://www.ncbi.nlm.nih.gov/pubmed/35475201 http://dx.doi.org/10.1002/jgh3.12730 |
work_keys_str_mv | AT nakanodan effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT kawaguchitakumi effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT tsutsumitsubasa effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT hayakawamasako effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT yoshiosachiyo effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT kogahironori effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells AT torimuratakuji effectsofsglt2inhibitorontumorreleasingchemokinescytokinesinhep3bandhuh7cells |